Forest Laboratories and Almirall Announce FDA has Extended the Review Period for Aclidinium Bromide – Yahoo Finance

Forest Laboratories, Inc. (NYSE:FRX – News) and Almirall, S.A. (ALM.MC) announced today that the U.S. Food and Drug Administration (FDA) will require a three-month extension to complete its review of the data supporting the New Drug Application …

Leave a Reply

Your email address will not be published. Required fields are marked *